Clinical Trials Directory

Trials / Completed

CompletedNCT02768233

Medication-overuse Headache: The Effect of a Patient Educational Programme as an add-on to Standard Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
98 (actual)
Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the influence of personality profiles in patients with MOH and to evaluate the effect of a custom-made educational programme as an add-on to standard treatment as compared to standard treatment alone in MOH patients using a randomized controlled trial (RCT) design.

Detailed description

Worldwide, two percent of the population suffers from medication-overuse headache (MOH), a paradox condition where the headache is caused by overuse of headache medication. Common treatment is withdrawal, but there is no consensus on what constitutes the best treatment. The study consists of a RCT with MOH patients randomized to standard treatment versus standard treatment + a 12-week, 6-session educational programme as add-on. The programme is based on theory of motivational interviewing, and patients can choose between individualized education or education in groups. Primary endpoint: Headache frequency measured by self-reported headache diary on number of days with headache pre-vious month. Secondary endpoints: NEO-FFI-3 personality test, coping strategies, pain intensity, bothersomeness, patient satis-faction and reported medication intake.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEducational programmeThe 6-session educational programme is based on theory of motivational interviewing, and patients can choose between individualized education or education in groups. The standard treatment consists of withdrawal and consultations by neurologist.

Timeline

Start date
2015-10-15
Primary completion
2018-07-01
Completion
2019-01-01
First posted
2016-05-11
Last updated
2023-01-04

Source: ClinicalTrials.gov record NCT02768233. Inclusion in this directory is not an endorsement.